Stay up-to-date on our latest developments
Regulated Information - Transparency Statement
Leuven, Belgium – Pursuant to Belgian transparency legislation (Law of 2 May 2007), ThromboGenics NV (Euronext Brussels: THR) received a transparency notification on 27 January 2017 from Mr Thomas M Clay and from Mr Landon T. Clay and controlled entities (East Hill Hedge Fund LLC, Monadnock Charitable Lead Annuity Trust, Clay Fellowships Charitable Trust en The Clay Mathematics Institute, Inc., or the 'East Hill Management Company LLC).
Thomas M. Clay notified that, on 27 January 2017, the ThromboGenics shares controlled by himself have decreased to 1,122,999 shares, or 3.11% of the current 36,094,349 outstanding ThromboGenics shares.
Landon T. Clay notified that, on 27 January 2017, the ThromboGenics shares controlled by himself and entities under his control have increased to 2,238,556, or 6.20% of the current 36,094,349 outstanding ThromboGenics shares.
On 27 January 2016, based on all received transparency declarations received, ThromboGenics NV is aware of the following participations:
|Shareholder||number of securities||% of voting rights|
|Mr Landon T. Clay and entities controlled by him||2,238,556||6.20%|
|Mr Thomas M. Clay and entities controlled by him||1,122,999||3.11%|
|Baron Philippe Vlerick and entities controlled by him||2,324,719||6.44%|